Nuvo Pharmaceuticals Inc MRVFF

Buyout

[lscfa]

Merry Christmas

https://www.miravohealthcare.com/news/miravo-healthcare-enters-into-definitive-agreement-to-be-acquired-by-searchlight-pharma-inc/

[VictorKonstan]

Turn out the lights...the party is over!

[UglyKidStock]

Shareholder Robbery under the distraction of Xmas.    Stealing it for debt - cash with no stock option over hang and all of the good news on approvals coming in first half 2023.    Without the options 'warrants owed to Red Oak the Enterprise value is quite low.  These things were rapidly expiring already.   What is Red Oaks angle ?  

[lscfa]

I agree it's highway robbery and a sellout by mgmt.  NR does not mention co. had $31 million CAD in cash at Sept 30, making net debt only $75 million CAD. This means the buyout offer only values next year's ebitda at 4.165x using Bllom Burton's forecast of ebitda. If the multiple is raised to 5x the offer would need to be $2.94/sh. I'm voting no to this stink bid. https:/

[lscfa]

more pricing options added to table...   $ 000 Cdn Buy out offer Increased multiple Increased multiple Increased multiple 2023 ebitda  21.7 21.7 21.7 21.7 Multiple

[VictorKonstan]

Absolutely a total sell-out!  This is way beyond highway robbery.  Lying Lazy Ledger has sold out all the company's shareholders...and why would Red Oak support this horrific offer?  Sitting on over thirty million dollars as well!  Shameful...Too lazy and incompetent to seek out better and more equitable alternatives.

[lscfa]

Bloom Burton's own report says value is $1.50/sh but they reduced it by 20% for liquidity.... We have made changes to our forecasts which result in our TP for MRV shares increasing to $1.20 (DCF: 12% discount rate with a further 20% liquidity discount). 

[UglyKidStock]

[e-mail] email investor relations and tell them you will vote against his attempted shareholder fraud

[lscfa]

We should all complain to mgmt and threaten a no vote. Sometimes it works.... https://stockhouse.com/news/press-releases/2020/07/30/seven-aces-and-trive-capital-amend-arrangement-agreement-to-increase-purchase

[Marathon11]

I'll be voting NO with my approx 125K shared. Will also have friends and family vote NO. Ridiculous.

[lscfa]

  Bloom Burton target price of $1.50 for Medexus implies a multiple of 7.74x on 2023 ebitda. https://www.bloomburton.com/research/MDP20221110.pdf

[baggerx99]

Damn disgusting.....maybe a counter offer may develop from some other phrma.

[lscfa]

Bloom Burton target price of $10.00 for Biosyent implies a multiple of 10x on 2023 ebitda. https://www.bloomburton.com/research/RX20221117.pdf

[lscfa]

Tables of peers...   $ 000 Cdn Miravo Medexus Biosyent Bloom TP 1.20 1.50 10.00 Shs o/s 11.4 19.6 12.3 Mkt cap 13.7

[lscfa]

vote no.....

[tenbagger_please]

Miravo EBITDA will fall off a cliff in a few years with patent expiries.  Do the same table based on 2025 or 2026 EBITDA.    Read the management information form.  120 parties contacted and 1.35 is the best Mrv could get.  Vote no.... then what?  Stock falls and no one else bids.  Then cash flow starts to fall every year until the company dilutes shareholders

[Spuds21]

And to you TEN Bag - P Off.  Id rather lose the whole lot then give these crooks the satifaction of the crime they are comitting - you on the otherhand thats right - board of diectors eh... Actually - techically - what the old sorts paid - we have lost it all - and this 1.30 represents that - total loss.  Rotten lying crooks. ouch - sensitve